1. Home
  2. ATAI vs NXJ Comparison

ATAI vs NXJ Comparison

Compare ATAI & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • NXJ
  • Stock Information
  • Founded
  • ATAI 2018
  • NXJ 1999
  • Country
  • ATAI Germany
  • NXJ United States
  • Employees
  • ATAI N/A
  • NXJ N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • NXJ Finance/Investors Services
  • Sector
  • ATAI Health Care
  • NXJ Finance
  • Exchange
  • ATAI Nasdaq
  • NXJ Nasdaq
  • Market Cap
  • ATAI 444.7M
  • NXJ 468.0M
  • IPO Year
  • ATAI 2021
  • NXJ N/A
  • Fundamental
  • Price
  • ATAI $2.66
  • NXJ $11.42
  • Analyst Decision
  • ATAI Strong Buy
  • NXJ
  • Analyst Count
  • ATAI 2
  • NXJ 0
  • Target Price
  • ATAI $11.00
  • NXJ N/A
  • AVG Volume (30 Days)
  • ATAI 5.7M
  • NXJ 74.9K
  • Earning Date
  • ATAI 08-12-2025
  • NXJ 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • NXJ 3.27%
  • EPS Growth
  • ATAI N/A
  • NXJ N/A
  • EPS
  • ATAI N/A
  • NXJ N/A
  • Revenue
  • ATAI $1,863,000.00
  • NXJ N/A
  • Revenue This Year
  • ATAI $554.22
  • NXJ N/A
  • Revenue Next Year
  • ATAI N/A
  • NXJ N/A
  • P/E Ratio
  • ATAI N/A
  • NXJ N/A
  • Revenue Growth
  • ATAI 572.56
  • NXJ N/A
  • 52 Week Low
  • ATAI $1.03
  • NXJ $10.06
  • 52 Week High
  • ATAI $2.99
  • NXJ $12.24
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 62.17
  • NXJ 57.26
  • Support Level
  • ATAI $2.62
  • NXJ $11.39
  • Resistance Level
  • ATAI $2.99
  • NXJ $11.50
  • Average True Range (ATR)
  • ATAI 0.24
  • NXJ 0.07
  • MACD
  • ATAI 0.03
  • NXJ 0.02
  • Stochastic Oscillator
  • ATAI 67.01
  • NXJ 74.61

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

Share on Social Networks: